TEE
MNOV icon

Tibra Equities Europe’s MediciNova MNOV Stock Holding History

Tibra Equities Europe’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-84,800
Closed -$360K – 136
2021
Q2 		$360K Buy
+84,800
New +$365K 0.11% 47
2018
Q1 		– Sell
-33,791
Closed -$219K – 237
2017
Q4 		$219K Buy
+33,791
New +$224K 0.09% 125

Other funds holding MNOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Tibra Equities Europe's MNOV Position: Q3 2021 in Review

Tibra Equities Europe sold out of MediciNova (MNOV) in Q3 2021, closing a stake of 84,800 shares — an estimated $360K sold.

Tibra Equities Europe first reported a position in MNOV in Q4 2017 and held it in 2 quarters. The position peaked at $360K in Q2 2021. 39 funds tracked by Wall St. Rank hold MNOV as of Q3 2021.

  • Tibra Equities Europe reported no remaining MediciNova position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 84,800 MediciNova shares in Q3 2021, an estimated $360K.
  • Tibra Equities Europe first reported a position in MediciNova in Q4 2017 and held it in 2 quarters.
  • Tibra Equities Europe's MediciNova position peaked at $360K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held MediciNova as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.